Published in Brain Res on March 11, 1985
Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci (2011) 1.71
Cutaneous innervation of the human face as assessed by skin biopsy. J Anat (2012) 0.96
The influence of the trigeminal ganglion on carotid blood flow in anaesthetized guinea-pigs. Br J Pharmacol (1994) 0.85
Sympathetic and parasympathetic interaction in vascular control of the nasal mucosa in anaesthetized cats. J Physiol (1994) 0.83
Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev (2017) 0.81
Tonabersat (SB-220453) a novel benzopyran with anticonvulsant properties attenuates trigeminal nerve-induced neurovascular reflexes. Br J Pharmacol (2001) 0.81
Sphenopalatine (pterygopalatine) ganglion stimulation and cluster headache: new hope for ye who enter here. Cephalalgia (2013) 0.79
Capsaicin-insensitive sensory-efferent meningeal vasodilatation evoked by electrical stimulation of trigeminal nerve fibres in the rat. Br J Pharmacol (1999) 0.79
Parasympathetic reflex vasodilation in the cerebral hemodynamics of rats. J Comp Physiol B (2014) 0.78
Trigeminal nerve ganglion stimulation-induced neurovascular reflexes in the anaesthetized cat: role of endothelin(B) receptors in carotid vasodilatation. Br J Pharmacol (1999) 0.76
Current Approaches to Neuromodulation in Primary Headaches: Focus on Vagal Nerve and Sphenopalatine Ganglion Stimulation. Curr Pain Headache Rep (2016) 0.75
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet (2001) 6.61
New appendix criteria open for a broader concept of chronic migraine. Cephalalgia (2006) 5.97
Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia (2000) 3.32
Hypothalamic activation in cluster headache attacks. Lancet (1998) 3.32
The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache. Cephalalgia (2005) 2.86
Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia (2002) 2.78
A triptan too far? J Neurol Neurosurg Psychiatry (1998) 2.71
Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med (1999) 2.67
EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol (2006) 2.43
EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force. Eur J Neurol (2009) 2.39
Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia (2010) 2.18
Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia (2007) 2.11
Premonitory symptoms in migraine: an electronic diary study. Neurology (2003) 1.81
Brainstem activation specific to migraine headache. Lancet (2001) 1.80
The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab (1999) 1.77
Migraine, aura, and cortical spreading depression: why are we still talking about it? Ann Neurol (2001) 1.74
Greater occipital nerve injection in primary headache syndromes--prolonged effects from a single injection. Pain (2006) 1.72
Proposals for new standardized general diagnostic criteria for the secondary headaches. Cephalalgia (2009) 1.68
Migraine: preventive treatment. Cephalalgia (2002) 1.63
Activation of the trigeminovascular system by mechanical distension of the superior sagittal sinus in the cat. Cephalalgia (1992) 1.62
A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain (2005) 1.59
Brainstem influences on the cephalic circulation: experimental data from cat and monkey of relevance to the mechanism of migraine. Headache (1983) 1.58
Intravenous aspirin (lysine acetylsalicylate) in the inpatient management of headache. Neurology (2010) 1.58
Oral zolmitriptan is effective in the acute treatment of cluster headache. Neurology (2000) 1.56
Ergotamine in the acute treatment of migraine: a review and European consensus. Brain (2000) 1.52
Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a review. Cephalalgia (2004) 1.45
The clinical characteristics of headache in patients with pituitary tumours. Brain (2005) 1.44
Cortical spreading depression-associated cerebral blood flow changes induced by mechanical stimulation are modulated by AMPA and GABA receptors. Cephalalgia (2010) 1.44
EFNS guideline on the drug treatment of migraine - report of an EFNS task force. Eur J Neurol (2006) 1.43
Vasodilator agents and supracollicular transection fail to inhibit cortical spreading depression in the cat. Cephalalgia (1999) 1.38
Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia (2009) 1.29
Functional magnetic resonance imaging in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing. Ann Neurol (1999) 1.26
The periaqueductal grey matter modulates trigeminovascular input: a role in migraine? Neuroscience (2001) 1.24
Diagnostic delays and mis-management in cluster headache. Acta Neurol Scand (2004) 1.22
Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Brain Res (1993) 1.21
Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater. Brain (2003) 1.21
Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS). J Headache Pain (2012) 1.19
Animal models of migraine: looking at the component parts of a complex disorder. Eur J Neurosci (2006) 1.16
Decreased carotid arterial resistance in cats in response to trigeminal stimulation. J Neurosurg (1984) 1.15
Deep brain stimulation for intractable chronic cluster headache: proposals for patient selection. Cephalalgia (2004) 1.11
What happens to new-onset headache presented to primary care? A case-cohort study using electronic primary care records. Cephalalgia (2008) 1.10
Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption. Br J Pharmacol (1993) 1.10
Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception. Ann Neurol (2004) 1.08
Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides. Neuropeptides (1990) 1.06
PET and MRA findings in cluster headache and MRA in experimental pain. Neurology (2000) 1.06
Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNA1A mutation. Dev Med Child Neurol (2002) 1.05
Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study. Brain (1996) 1.05
Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels. Br J Pharmacol (2002) 1.04
Stimulation of the middle meningeal artery leads to Fos expression in the trigeminocervical nucleus: a comparative study of monkey and cat. J Anat (1999) 1.04
Neuropeptides in migraine and cluster headache. Cephalalgia (1994) 1.03
Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation. Br J Pharmacol (2003) 1.03
Magnetic resonance angiography in facial and other pain: neurovascular mechanisms of trigeminal sensation. J Cereb Blood Flow Metab (2001) 1.02
SUNCT syndrome responsive to intravenous lidocaine. Cephalalgia (2004) 1.02
Hypothalamic involvement and activation in cluster headache. Curr Pain Headache Rep (2001) 1.02
Calcitonin gene-related peptide and nitric oxide in the trigeminal ganglion: cerebral vasodilatation from trigeminal nerve stimulation involves mainly calcitonin gene-related peptide. J Auton Nerv Syst (1998) 1.02
Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study. Neurology (2003) 1.02
Unilateral photophobia or phonophobia in migraine compared with trigeminal autonomic cephalalgias. Cephalalgia (2008) 1.01
Dopamine and migraine: biology and clinical implications. Cephalalgia (2007) 1.01
Trigeminovascular nociceptive transmission involves N-methyl-D-aspartate and non-N-methyl-D-aspartate glutamate receptors. Neuroscience (1999) 1.00
Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area. Pain (2004) 1.00
The mode of action of sumatriptan is vascular? A debate. Cephalalgia (1994) 0.98
Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism. Brain (1996) 0.98
Gray matter changes related to chronic posttraumatic headache. Neurology (2009) 0.98
Reproductive patterns of three species of macaques. Fertil Steril (1971) 0.98
Substance P receptor antagonists in the therapy of migraine. Expert Opin Investig Drugs (2001) 0.98
Fos expression in the midbrain periaqueductal grey after trigeminovascular stimulation. J Anat (2001) 0.98
SUNCT syndrome secondary to prolactinoma. J Neurol Neurosurg Psychiatry (2003) 0.98
Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors. Br J Pharmacol (2004) 0.97
Secondary cluster headache responsive to sumatriptan. J Neurol Neurosurg Psychiatry (1995) 0.97
Familial typical migraine: linkage to chromosome 19p13 and evidence for genetic heterogeneity. Neurology (1998) 0.97
Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat. Brain (1997) 0.97
Prolactinomas, dopamine agonists and headache: two case reports. Eur J Neurol (2003) 0.96
Benign cough headache. Cephalalgia (2002) 0.96
No change in the structure of the brain in migraine: a voxel-based morphometric study. Eur J Neurol (2003) 0.96
Glyceryl trinitrate triggers premonitory symptoms in migraineurs. Pain (2004) 0.95
Placebo response in cluster headache trials: a review. Cephalalgia (2003) 0.95
Amylin: localization, effects on cerebral arteries and on local cerebral blood flow in the cat. ScientificWorldJournal (2001) 0.94
SUNCT syndrome: prolonged attacks, refractoriness and response to topiramate. Neurology (2002) 0.94
Evidence for an X-linked genetic component in familial typical migraine. Hum Mol Genet (1998) 0.94
Topiramate inhibits trigeminovascular neurons in the cat. Cephalalgia (2004) 0.93
Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat. Eur J Neurosci (2006) 0.93
Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism. Br J Pharmacol (2003) 0.92
Why headache treatment fails. Neurology (2003) 0.92
6-Mercaptopurine-related leucopenia and in vivo xanthine oxidase activity. Lancet (1986) 0.92
Cluster headache. Cephalalgia (2000) 0.92
Distribution of 5-HT(1B), 5-HT(1D) and 5-HT(1F) receptor expression in rat trigeminal and dorsal root ganglia neurons: relevance to the selective anti-migraine effect of triptans. Brain Res (2010) 0.91
Significance of atypical presentation of symptomatic SUNCT: a case report. J Neurol Neurosurg Psychiatry (2001) 0.91
Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat. Exp Neurol (1998) 0.90
Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception. J Pharmacol Exp Ther (2005) 0.90
Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception. J Pharmacol Exp Ther (2004) 0.89
Intravenous acetylsalicylic acid inhibits central trigeminal neurons in the dorsal horn of the upper cervical spinal cord in the cat. Headache (1994) 0.89
Anti-migraine compounds fail to modulate the propagation of cortical spreading depression in the cat. Eur Neurol (1994) 0.89
The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity within the trigeminocervical complex following superior sagittal sinus stimulation in the cat. Brain Res (2001) 0.88
Clinical features of headache at altitude: a prospective study. Neurology (2003) 0.88
Fos expression in the trigeminocervical complex of the cat after stimulation of the superior sagittal sinus is reduced by L-NAME. Neurosci Lett (1999) 0.88
Bilateral paroxysmal hemicrania or bilateral paroxysmal cephalalgia, another novel indomethacin-responsive primary headache syndrome? Cephalalgia (2005) 0.88
Inhibition of nociceptive dural input in the trigeminal nucleus caudalis by somatostatin receptor blockade in the posterior hypothalamus. Pain (2005) 0.87
Neuropeptides in the cerebral circulation: relevance to headache. Cephalalgia (1995) 0.87
Comparative effects of stimulation of the trigeminal ganglion and the superior sagittal sinus on cerebral blood flow and evoked potentials in the cat. Brain Res (1988) 0.87
A simple method, using 2-hydroxypropyl-beta-cyclodextrin, of administering alpha-chloralose at room temperature. J Neurosci Methods (1997) 0.87